1. Home
  2. APLT vs ECC Comparison

APLT vs ECC Comparison

Compare APLT & ECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • ECC
  • Stock Information
  • Founded
  • APLT 2016
  • ECC N/A
  • Country
  • APLT United States
  • ECC United States
  • Employees
  • APLT N/A
  • ECC N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • ECC
  • Sector
  • APLT Health Care
  • ECC
  • Exchange
  • APLT Nasdaq
  • ECC NYSE
  • Market Cap
  • APLT 971.6M
  • ECC 940.6M
  • IPO Year
  • APLT 2019
  • ECC N/A
  • Fundamental
  • Price
  • APLT $9.65
  • ECC $9.63
  • Analyst Decision
  • APLT Strong Buy
  • ECC Buy
  • Analyst Count
  • APLT 5
  • ECC 2
  • Target Price
  • APLT $12.50
  • ECC $11.00
  • AVG Volume (30 Days)
  • APLT 1.6M
  • ECC 679.0K
  • Earning Date
  • APLT 11-15-2024
  • ECC 02-22-2024
  • Dividend Yield
  • APLT N/A
  • ECC 19.16%
  • EPS Growth
  • APLT N/A
  • ECC 369.44
  • EPS
  • APLT N/A
  • ECC 1.69
  • Revenue
  • APLT N/A
  • ECC $122,654,279.00
  • Revenue This Year
  • APLT N/A
  • ECC $36.58
  • Revenue Next Year
  • APLT $3,358.27
  • ECC $12.88
  • P/E Ratio
  • APLT N/A
  • ECC $5.93
  • Revenue Growth
  • APLT N/A
  • ECC 96.41
  • 52 Week Low
  • APLT $1.79
  • ECC $8.60
  • 52 Week High
  • APLT $9.98
  • ECC $11.79
  • Technical
  • Relative Strength Index (RSI)
  • APLT 67.47
  • ECC 44.88
  • Support Level
  • APLT $8.38
  • ECC $9.51
  • Resistance Level
  • APLT $9.29
  • ECC $9.74
  • Average True Range (ATR)
  • APLT 0.56
  • ECC 0.10
  • MACD
  • APLT 0.01
  • ECC 0.01
  • Stochastic Oscillator
  • APLT 79.75
  • ECC 43.39

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About ECC EAGLE POINT CREDIT CO LLC

Eagle Point Credit Co Inc is an externally managed, non-diversified closed-end management investment company.

Share on Social Networks: